Option Care Health Inc(OPCH)
USD --+0.00%
Reward55Moderate
Risk33Moderate
📊75%Data
Thin 4% profit margin
OPCH
+0.0 · +0.00%
USD · NASDAQ
Option Care Health Inc | Healthcare
Balanced
Market Cap:5.45Bn
ℹ️
Reward Rating
55
Moderate
Bottom 50% (model universe)
75% data coverage
ℹ️
Risk Rating
33
Moderate
Risk Assessment
ℹ️

Educational tool only – Scores are based on historical data and financial metrics for informational purposes. This is not financial advice or a recommendation to buy or sell any security. Always conduct your own research or consult a qualified financial adviser.

ℹ️ Educational tool only · More
Limited data coverage
We don't have enough public data on OPCH to score it reliably yet — Reward, Risk, Forecasts and Dividends tabs aren't available for this stock. The price chart and basic profile are still shown.
OTC / ADR stock — scores and fundamentals use data tagged in USD by our provider. The issuer may report in a different home currency (e.g. JPY), so treat figures as directional rather than precise.
Not available for limited-coverage stocks
The overview tab requires fundamentals and price history we don't have for this stock. The price chart is the most reliable view we have — try the Chart tab.

Market Performance

Stock returned +10.0% over the past year, broadly in line with market conditions.

Analyst Target

Analyst consensus price target: $40.00.

What is Option Care Health Inc?

offers home and alternate site infusion services in the United States.

OPCH · Verdict

Solid reward · moderate risk

OPCH scores well on balance sheet and cash flow with no major weaknesses flagged in the model.

Based on 88% data coverage

OPCH · Verdict

What’s working & what to watch

Strengths 2

  • Balance sheet80/100

    Interest covered 3.3×

  • Cash flow67/100

    5% free-cash-flow margin

No major weaknesses flagged.

Model-based scoring. For information only — not financial advice.

What is Option Care Health Inc?

offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.45B, and a P/E ratio of 26.7x.

Financial Highlights

Investment Breakdown

📈 Growth
Moderate growth momentum — positive trajectory without breakout acceleration.
💰 Profitability
Profitability metrics are mixed — margins may be under pressure.
⚠️ Risk
Below-average volatility supports a steadier risk profile.
💸 Valuation
Valuation appears fair relative to current fundamentals.

OpenBook Logo Analysis

Reward: Moderate (55)

The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.

For informational purposes only. Not financial advice.

Company Information
SectorHealthcare
Market Cap5.45B
P/E Ratio26.6667
Dividend YieldN/A
52 Week High36.8
52 Week Low24.235
Last AnnualDecember
IPO Date8/15/1996
IncorporatedUSA
Shares Outstanding159M
No. of Employees8,000
IndustryMedical Care Facilities
ExchangeNASDAQ
Beta0.84
CurrencyUSD